Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein Hox-C9 is a sequence-specific transcription factor encoded by the HOXC9 gene and part of the homeobox family, which plays a critical role in developmental patterning and morphogenesis. It establishes positional identity of cells along the body axis during embryogenesis, acting within the HOXC gene cluster on chromosome 12. Dysregulation or aberrant expression of HOXC9 has been implicated in certain cancers and may affect tumor immune microenvironment, but no existing drugs directly target HOXC9 in clinical practice.
Not applicable to standard drugs; regulation is usually via gene expression modulation, epigenetic mechanisms, or experimental RNA/protein interference.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein Hox-C9 (HOXC9).